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Summary
Charcot-Marie-Tooth disease (CMT) is a heteroge-
neous group of disorders that affect the peripheral
nervous system. Three loci are known for the auto-
somal dominant forms of axonal CMT (CMT2), but
none have yet been identified for autosomal recessive
axonal CMT (ARCMT2). We have studied a large
consanguineous Moroccan ARCMT2 family with
nine affected sibs. The onset of CMT was in the 2d
decade in all affected individuals who presented with
a severe motor and sensory neuropathy, with proximal
muscle involvement occurring in some patients. After
exclusion of known loci for CMT2 and for demye-
linating ARCMT2, a genomewide search was per-
formed. Evidence for linkage was found with markers
on chromosome 1q. The maximum pairwise LOD
score was above the threshold value of 3.00, for mark-
ers D1S514, D1S2715, D1S2777, and D1S2721, and
it reached 6.10 at the loci D1S2777, D1S2721, and
D1S2624, according to multipoint LOD-score anal-
ysis. These markers defined a region of homozygosity
that placed the gene in a 4.4-cM interval. Moreover,
a recombination event detected in an unaffected 48-
year-old individual excludes the D1S506 marker,
thereby reducing the interval to 1.7 cM. In addition,
the P0 gene, an attractive candidate because of both
its location on chromosome 1q and its role in myelin
structure, was excluded by physical mapping and di-
rect sequencing.
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Introduction
Charcot-Marie-Tooth disease (CMT; MIM 118200),
the most common hereditary motor and sensory neu-
ropathy, is known to be a clinically, electrophysiolog-
ically, neuropathologically, and genetically heteroge-
neous group of disorders that affect the peripheral
nervous system. Advances in molecular genetics have
contributed to our understanding of both the path-
ogenesis of CMT and the classification of its forms
on the basis of electrophysiological, morphological,
and genetic criteria (Gabree¨ls-Festen et al. 1993).
However, the autosomal recessive forms of CMT are
still poorly documented. Four loci have been identified
for demyelinating forms of the disease (Ben Othmane
et al. 1993; Bolino et al. 1996; Kalaydjieva et al. 1996;
LeGuern et al. 1996), but the corresponding genes are
not yet known.
To date, no locus has been associated with auto-
somal recessive axonal forms of CMT (ARCMT2),
because of the apparent rarity of these forms. Indeed,
only a few families with established consanguinity
have been reported. In these families, the disease was
found to be both more severe and earlier in onset than
autosomal dominant axonal CMT (Harding and Tho-
mas 1980; Ouvrier et al. 1981; Gabree¨ls-Festen et al.
1991). In northern Africa, consanguineous marriages
are common, and autosomal recessive traits, including
ARCMT2, are frequent. In the present study, we per-
formed a genomewide search in a large consanguin-
eous Moroccan family presenting with ARCMT2. We
found evidence for linkage to chromosome 1q21.2-
q21.3.
Family and Methods
Family
A large consanguineous family of Moroccan ances-
try was examined in the Service de Neurologie of the
Hoˆpital des Spe´cialite´s, Rabats-Instituts, in Rabat,
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Figure 1 Haplotype reconstruction for chromosome 1q
markers in a Moroccan family with ARCMT2. The consanguinity
loop between individuals 1 and 2 could not be precisely charac-
terized and is represented by a dashed line. Deduced haplotypes
for individuals 2 and 34 are bracketed. Microsatellite markers are
ordered, according to the Ge´ne´thon genetic map, from centromere
(top) to telomere (bottom). The hatched area represents the com-
mon region of homozygosity for all affected individuals. Observed
recombinations are indicated by arrows.
Morocco. Clinical and electrophysiological examina-
tions were performed on 17 family members, includ-
ing 9 affected individuals, 5 at-risk relatives, and 3
parents (fig. 1). Individuals were considered to be af-
fected when they presented, at least in the lower limbs,
with signs of motor and sensory neuropathy and ab-
normal electrophysiological findings.
Genotyping
Blood samples from the 17 individuals were ob-
tained after informed consent was given, and genomic
DNA was extracted, by use of standard procedures,
in the Laboratoire de Neuroge´ne´tique of the Hoˆpital
des Spe´cialite´s, Rabats-Instituts, in Rabat. For the ge-
nomewide search, the ABI PRISM linkage-mapping
set version 2 (Perkin-Elmer/Applied Biosystems) was
used. The set consists of 400 fluorescent microsatellite
markers, selected from the Ge´ne´thon human linkage
map (Weissenbach et al. 1992; Gyapay et al. 1994;
Dib et al. 1996), that cover the entire human genome,
with a resolution of ∼10 cM (Schuster et al. 1996).
The markers were amplified by PCR performed with
the following conditions: 60 ng genomic DNA, 5 pmol
each primer, 2.5 mM of each dNTP, 1.5 ml 10# PCR
buffer II, and 0.6 U AmpliTaq Gold DNA polymerase,
in a final volume of 15 ml. Samples were incubated in
a thermocycler for 12 min at 95C to initiate acti-
vation of the AmpliTaq Gold DNA polymerase; for
15 s at 94C, 15 s at 55C, and 30 s at 72C for 10
cycles; for 15 s at 89C, 15 s at 55C, and 30 s at
72C, for 25 additional cycles; and, for a final exten-
sion, for 10 min at 72C. After amplification, PCR
products were pooled, combined in a tube with
GeneScan 400HD size standard, and loaded onto a 4%
acrylamide gel by use of the ABI PRISM 377 DNA Se-
quencer (Perkin-Elmer). CEPH 1347-02 DNA was used
as a control.
Linkage Analysis
Pairwise and multipoint LOD scores were calculated
by use of the MLINK and LINKMAP programs of the
FASTLINK package (Scha¨ffer et al. 1994); a fully pen-
etrant autosomal recessive trait with a disease-allele fre-
quency of .0001 and an equal recombination fraction
in males and females was assumed. We assigned equal
frequencies to the alleles observed in the family studied.
At-risk individuals 44, 48, and 61—who were clinically
and electrophysiologically normal at age 35, 42, and 48
years, respectively—were considered to be unaffected;
however, the status of individuals 58 and 59, who had
no clinical and electrophysiological signs, was consid-
ered to be unknown because of their age—13 and 18
years, respectively—at examination. Haplotypes were
constructed according to the principles of Thompson
(1987). The order of the markers was that of the con-
sensus CEPH/Ge´ne´thon chromosome 1 linkage map of
the Genome Database (fig. 1).
Physical Mapping of the P0 Locus
The P0 primers used to screen the CEPH YAC li-
brary and YAC DNA were as follows: CCT GAC TAC
ATT GTC CTC CC (forward primer, intron 2) and
CTG GAT GCG CTC TTT GAA GGA (reverse primer,
exon 3). Primers for D1S2635, D1S2771, D1S2675,
and D1S2705 were the same as those previously de-
scribed by Dib et al. (1996). Total yeast DNA was
extracted by the means described by Blanchard and
Nowotny (1994). PCR amplification was performed
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Table 1
Pairwise LOD Scores for 16 Chromosome 1q Markers
LOD SCORE AT v =
MARKERa .00 .01 .05 .10 .20 .30 .40
D1S2746 1.88 1.83 1.65 1.41 .91 .45 .12
D1S514 3.00 2.95 2.70 2.36 1.62 .89 .28
D1S498 2.23 2.17 1.96 1.69 1.15 .63 .21
D1S2858 1.43 1.39 1.22 1.02 .64 .31 .08
D1S305 2.81 2.75 2.49 2.16 1.48 .83 .28
D1S2715 3.83 3.73 3.34 4.86 1.91 1.01 .30
D1S303 2.95 2.87 2.57 2.21 1.49 .81 .25
D1S2777 3.13 3.05 2.74 2.35 1.59 .87 .27
D1S2721 3.34 3.26 2.92 2.50 1.67 .89 .26
D1S2624 2.71 2.63 2.33 1.96 1.25 .62 .17
D1S506  1.73 2.09 1.96 1.41 .78 .24
D1S2635  .62 1.64 1.78 1.44 .86 .28
D1S2771  1.65 .45 .07 .11 .08 .02
D1S2675  4.50 1.92 .97 .28 .06 .01
D1S2705  2.09 .27 .29 .50 .35 .13
D1S2768  1.35 .08 .30 .38 .23 .06
a Ordered from centromere (top) to telomere (bottom).
in 50 ml containing 5 ml 10 # PCR buffer, 10 pmol
of each dNTP, 20 pmol of each primer, 300 ng yeast
genomic DNA, and 1.5 ml Taq DNA polymerase (Pro-
mega). After an initial cycle of 5 min at 95C, 30
cycles of amplification were performed for 1 min at
95C, 1 min at 52C (for all primers except P0 at
60C), and 1 min at 72C. The reaction was completed
by a terminal elongation step for 7 min at 72C. PCR
products were visualized, under UV light, after elec-
trophoresis in 1.5% agarose gel.
Sequencing
Exons 1–5 and the coding part of exon 6 of the P0
gene were amplified by PCR using primers described by
Hayasaka et al. (1993) and using the standard procedure
done in patient 41 (fig. 1). Samples were purified by use
of the QIAquick PCR Purification Kit (QIAGEN). They
were then sequenced on both strands and were analyzed
by use of The Big Dye Terminator Cycle Sequencing
Ready Reaction Kit (Applied Biosystems) and the ABI
PRISM 377 DNA Sequencer (Perkin-Elmer).
Results
Clinical and Electrophysiological Findings
Age at onset of the disease was in the 2d decade
(10–18 years) in all nine patients. The age at exam-
ination was 15–49 years. All patients presented with
weakness and wasting of the distal limb muscles and
had areflexia predominantly in the lower limbs. Pes
cavus were present in seven cases. Of the six patients
who had evident involvement of the proximal mus-
cles, three had muscle weakness and wasting of both
limb girdles, which are associated with severe ky-
phoscoliosis. The neuropathy was severe and was re-
sponsible for loss of autonomy in five cases.
Motor-nerve conduction velocity was normal or
slightly reduced in all patients: mean motor-nerve con-
duction velocities were 53  9.2 m/s for the median
nerve, 50.1  8.8 m/s for the ulnar nerve, and 39.2
 6.5 m/s for the peroneal nerve. Sensory-nerve ac-
tion potentials were decreased or absent in all pa-
tients. These electrophysiological data reflected an ax-
onal-disorder process. A superficial peroneal-nerve
biopsy performed in patient 56 (fig. 1) confirmed the
presence of axonal neuropathy with an important loss
of large myelinating fibers and few clusters of regen-
eration. The detailed clinical, electrophysiological,
and neuropathological findings will be reported else-
where (Birouk et al., unpublished data).
Linkage Analysis
To exclude candidate loci, we first performed a two-
point linkage study of the parents and affected individ-
uals to determine the four loci responsible for autosomal
recessive demyelinating CMT on 8q13-21.1 (Ben Oth-
mane et al. 1993), 11q23 (Bolino et al. 1996), 5q23-33
(LeGuern et al. 1996), and 8q24 (Kalaydjieva et al.
1996); and to determine the three loci responsible for
autosomal dominant axonal CMT on 3q13-22 (Kwon
et al. 1995), 7p14 (Ionasescu et al. 1996), and 1p35-36
(Saito et al. 1997). Negative LOD scores were obtained
for all these loci (data not shown).
A genomewide search was conducted on the affected
individuals and their parents. After genotyping ∼25%
of the autosomal genome, homozygosity was observed
with marker D1S498 in all patients (fig. 1). Pairwise
LOD-score analysis at this locus generated a positive
value of 2.23 at recombination fraction (v) 0 (table 1),
which suggested linkage between the disease and marker
D1S498. Linkage analysis was extended to 12 markers
covering 21 cM in this region. LOD scores above the
threshold of 3 at v = 0 were observed for the D1S514,
D1S2715, D1S2777, and D1S2721 markers (table 1).
For D1S303, D1S2777, D1S2721, and D1S2624, the
multipoint LOD score reached the value of 6.10 (fig. 2).
According to the Ge´ne´thon map, haplotype recon-
struction revealed that all patients shared a common
4.4-cM region of homozygosity, encompassing the
D1S2777, D1S2721, D1S2624, and D1S506 markers.
The centromeric boundary of this interval corre-
sponded to an inferred recombination between D1S2777
and D1S303, which was observed in individuals 3, 5, 6,
8, 56, and 57 and which probably occurred in a common
ancestor of individuals 2 and 40. This shows that
D1S303 is centromeric to D1S2777, although these
markers are placed at the same locus on the Ge´ne´thon
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Figure 2 Multipoint linkage analysis in a Moroccan family
with ARCMT2. The genetic distances are represented as on the
Ge´ne´thon chromosome 1 map. Horizontal dashed lines indicate
the limit of exclusion (LOD score = 2) and the limit of significant
linkage (LOD score = 3). Markers of the region of homozygosity
are boxed. The interval containing P0 is indicated by the thicker
unbroken line.
Table 2
PCR Amplification of YAC DNA with Primers for Markers of the
1q21-q23 Region and for the P0 Gene
YACa
MARKER 777D5 884D9
D1S2635  
D1S2771  
D1S2675  
D1S2705  
P0  
a A plus sign () denotes presence of amplification, and a minus
sign () denotes absence of amplification.
map. The telomeric boundary of the region of homo-
zygosity is delimited by the inferred recombination be-
tween D1S506 and D1S2635, which was observed in
patients 3, 5, 6, and 8 and in their unaffected mother.
This limit is supported by the recombination event de-
tected in patient 42, which placed the gene centromeric
to D1S2635. Moreover, in at-risk individual 61, who
can be considered to be normal because he is asymp-
tomatic at age 48 years, the recombination between
D1S2624 and D1S506 reduced the candidate interval to
a 1.7-cM region.
Physical Mapping and Sequencing of the P0 Gene
Since the receptor of the Fc fragment of immuno-
globulin type II (FcgRII), which physically colocalized
with the P0 gene within a 130-kb region (Pham-Dinh et
al. 1993), was telomeric to D1S2635 in the National
Center for Biotechnology Information GeneMap’98, the
CEPH YAC library was screened by PCR with P0-spe-
cific primers. Amplification signals were obtained for
YACs 777D5 and 884D9. Both YACs were tested with
markers D1S2635, D1S2771, D1S2675, and D1S2705.
P0 was colocalized with D1S2675 and D1S2705 on YAC
884D9, but only with D1S2705 on YAC 777D5. No
signal was obtained for D1S2635 and D1S2771 (table
2). No mutations were revealed by direct DNA sequenc-
ing of exons 1–5 and the 5′ portion of exon 6 of the P0
gene corresponding to the entire coding region in af-
fected individual 41.
Discussion
This study of a large consanguineous Moroccan fam-
ily has resulted in the identification of the first locus for
ARCMT2 on the long arm of chromosome 1. The pa-
tients presented with classic clinical signs of CMT, but,
in addition, the majority of patients also had pro-
nounced impairment of the proximal limb muscles. Even
though onset of CMT is in the 2d decade, by that time
neuropathy is already very severe, with four individuals
being dependent on a wheelchair. The electrophysiol-
ogical and neuropathological data indicated that the dis-
ease was axonal CMT.
In all patients, homozygosity for markers D1S2777,
D1S2721, D1S2624, and D1S506, as well as significant
positive LOD scores for D1S2777 and D1S2721, local-
ized the ARCMT2 gene within a 4.4-cM interval on
chromosome 1q21.2-21.3. The recombination event in
unaffected individual 61, who is 20 years older than the
family member with latest onset of the disease, further
reduced the candidate interval, to the 1.7-cM region be-
tween markers D1S303 and D1S506.
Physical mapping clearly showed that P0, which is
responsible for CMT1B, is telomeric to the candidate
genetic interval (D1S303–D1S506) defined by multi-
point LOD-score analysis (fig. 2). The genetic distance
between D1S506 and D1S2705, which colocalizes with
the P0 gene, is ∼8 cM. Furthermore, multipoint analysis
excluded the region between D1S2771 and D1S2768,
which contains the P0 locus (fig. 2). Since no mutations
were found in the coding region of the P0 gene, which
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was analyzed in individual 41, mutation of the P0 gene
cannot be responsible for ARCMT2.
The connexin 40 (Cx40) and connexin 50 (Cx50)
genes located on chromosome 1q were also potential
candidates, since mutations in the connexin 32 gene are
responsible for X-linked CMT (Bergoffen et al. 1993).
By physical mapping, the Cx40 gene, which encodes the
GJA5 protein and is responsible for cardiac-impulse
conduction (Kanter et al. 1994), was localized between
markers D1S2612 and D1S498 (Gelb et al. 1997), which
are 5 cM telomeric to the candidate interval. The Cx50
gene, which codes for the intrinsic lens-membrane pro-
tein MP70 and is responsible for zonular pulverulent
cataract (MIM 116200), is also outside the locus, since
it has been mapped to chromosome 1q21.1 by FISH
(Geyer et al. 1997). The responsible gene has yet to be
identified. Analysis of additional families with ARCMT2
will help to refine the candidate region, evaluate the
relative frequency of the chromosome 1q locus, and test
for further genetic heterogeneity.
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